Nasal Placebo

DRUG4 trials

Sponsors

Nastech Pharmaceutical Company, Inc., University of Athens, Children's Hospital Medical Center, Cincinnati, Virginia Commonwealth University

Conditions

Cystic FibrosisHeart DiseaseObesityObstructive Sleep Apnea Syndrome

Phase 1

A Comparison of Two Sedation Techniques in Children Undergoing Transthoracic Echocardiography (TTE)

CompletedNCT02250820

Children's Hospital Medical Center, CincinnatiHeart Disease

Start: 2014-11-30End: 2017-12-31Updated: 2020-01-21

Phase 2

A Study of Nasal PYY3-36 and Placebo for Weight Loss in Obese Subjects

CompletedNCT00537420

Nastech Pharmaceutical Company, Inc.Obesity

Start: 2007-10-31End: 2008-09-30Updated: 2008-09-15

Aztreonam Aerosol to Treat Cystic Fibrosis Nasal Disease

TerminatedNCT02730793

Virginia Commonwealth UniversityCystic Fibrosis

Start: 2017-01-31End: 2019-09-19Updated: 2021-01-28

Unknown Phase

Nasal Tramazoline and Dexamethazone in Obstructive Sleep Apnea (OSA) Patients Tramazoline and

CompletedNCT01601509

University of AthensObstructive Sleep Apnea Syndrome

Start: 2010-04-30End: 2012-05-31Updated: 2012-05-18